Is this FDA enforcement data for Becton Dickinson Infusion Therapy Systems, Inc. official?

Every record links directly to its primary FDA.gov source. Argus HQ aggregates and structures public FDA data; the verbatim FDA record is always the source of truth.

How many FDA actions has Becton Dickinson Infusion Therapy Systems, Inc. had?

Argus HQ has recorded 13 FDA events for Becton Dickinson Infusion Therapy Systems, Inc.: 0 warning letters, 13 recalls, 0 approvals, and 0 Form 483 inspection observations. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

What is the most recent FDA action against Becton Dickinson Infusion Therapy Systems, Inc.?

The most recent FDA event Argus HQ has on file for Becton Dickinson Infusion Therapy Systems, Inc. is dated 2025-07-02, with a severity rating of "high" in Argus HQ's classification. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

Does Argus HQ track new FDA actions for Becton Dickinson Infusion Therapy Systems, Inc. automatically?

Yes. Argus HQ ingests FDA sources daily, including FDA warning letters, recalls, drug and biologic approvals, and Form 483 inspection observations. When a new FDA action linked to Becton Dickinson Infusion Therapy Systems, Inc. is observed, this page's event count and history update automatically.

Becton Dickinson Infusion Therapy Systems, Inc.'s Complete FDA Record

FDA action counts

Total FDA actions	13
Warning letters	0
Recalls	13
Approval records	0
Form 483 inspection citations	0
Most recent action	July 2, 2025

Key takeaway: Argus HQ has recorded 13 FDA events for Becton Dickinson Infusion Therapy Systems, Inc.: 0 warning letters, 13 recalls, 0 approvals, and 0 inspection 483 observations. These events span from 2023-10-11 to 2025-07-02. The most severe rating Argus HQ has assigned across this history is "high". Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

Risk pattern analysis

Argus HQ analysis — not an FDA finding

This section is Argus HQ analysis, not an FDA finding. Becton Dickinson Infusion Therapy Systems, Inc. has 13 separate FDA recalls on file, more than a single isolated recall event. A pattern across multiple FDA touchpoints does not by itself establish that any specific product currently poses a risk; it reflects only the frequency of FDA engagement with this company as recorded in Argus HQ's database. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ does not independently verify FDA's underlying findings; this page summarizes what FDA has published and links back to the original FDA source for each event. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

Enforcement history

On 2025-07-02, Argus HQ recorded an FDA recall for Becton Dickinson Infusion Therapy Systems, Inc., rated "high" severity in Argus HQ's classification: Becton Dickinson Infusion Therapy Systems, Inc. — Class II recall: REF: 381811, BD Insyte Autoguard BC Pro Winged Shielded IV Catheter, 18 GA x…. On 2025-07-02, Argus HQ recorded an FDA recall for Becton Dickinson Infusion Therapy Systems, Inc., rated "high" severity in Argus HQ's classification: Becton Dickinson Infusion Therapy Systems, Inc. — Class II recall: REF: 382633, BD Insyte Autoguard BC Winged, Shielded IV Catheter with Blood Cont…. On 2025-07-02, Argus HQ recorded an FDA recall for Becton Dickinson Infusion Therapy Systems, Inc., rated "high" severity in Argus HQ's classification: Becton Dickinson Infusion Therapy Systems, Inc. — Class II recall: REF: 382944, BD Insyte Autoguard BC Pro Winged Shielded IV Catheter, 18 GA x 1.1…. On 2025-07-02, Argus HQ recorded an FDA recall for Becton Dickinson Infusion Therapy Systems, Inc., rated "high" severity in Argus HQ's classification: Becton Dickinson Infusion Therapy Systems, Inc. — Class II recall: REF: 382544 BD Insyte Autoguard Shielded IV Catheter, 18 GA x 1.16 in (1.3 x…. On 2025-07-02, Argus HQ recorded an FDA recall for Becton Dickinson Infusion Therapy Systems, Inc., rated "high" severity in Argus HQ's classification: Becton Dickinson Infusion Therapy Systems, Inc. — Class II recall: REF: 381923 BD Insyte Autoguard Winged Shielded IV Catheter, 22 GA x 1.00 in…. On 2025-07-02, Argus HQ recorded an FDA recall for Becton Dickinson Infusion Therapy Systems, Inc., rated "high" severity in Argus HQ's classification: Becton Dickinson Infusion Therapy Systems, Inc. — Class II recall: REF: 381423, BD Insyte Autoguard, Shielded IV Catheter, 22GA X 1.00 IN (0.9 X 25…. On 2025-07-02, Argus HQ recorded an FDA recall for Becton Dickinson Infusion Therapy Systems, Inc., rated "high" severity in Argus HQ's classification: Becton Dickinson Infusion Therapy Systems, Inc. — Class II recall: REF: 381433, BD Insyte Autoguard Shielded IV Catheter, 20GA x 1.00 in (1.1x25 mm…. On 2025-07-02, Argus HQ recorded an FDA recall for Becton Dickinson Infusion Therapy Systems, Inc., rated "high" severity in Argus HQ's classification: Becton Dickinson Infusion Therapy Systems, Inc. — Class II recall: REF: 381533, BD Insyte Autoguard Winged, Shielded IV Catheter, 20 GA x 1.00 in (…. On 2025-07-02, Argus HQ recorded an FDA recall for Becton Dickinson Infusion Therapy Systems, Inc., rated "high" severity in Argus HQ's classification: Becton Dickinson Infusion Therapy Systems, Inc. — Class II recall: REF: 381434 BD Insyte Autoguard Shielded IV Catheter, 20 GA x 1.16 in (1.1 x…. On 2025-05-28, Argus HQ recorded an FDA recall for Becton Dickinson Infusion Therapy Systems, Inc., rated "high" severity in Argus HQ's classification: Becton Dickinson Infusion Therapy Systems, Inc. — Class II recall: BD Cathena Safety IV Catheter BD Multiguard Technology 18 GA x 1.25 IN, REF: 386…. On 2024-08-07, Argus HQ recorded an FDA recall for Becton Dickinson Infusion Therapy Systems, Inc., rated "high" severity in Argus HQ's classification: Becton Dickinson Infusion Therapy Systems, Inc. — Class II recall: BD Insyte Autoguard BC, Shielded IV Catheter with Blood Control Technology, REF:…. On 2023-12-06, Argus HQ recorded an FDA recall for Becton Dickinson Infusion Therapy Systems, Inc., rated "high" severity in Argus HQ's classification: Becton Dickinson Infusion Therapy Systems Inc. — Class II recall: BD Insyte Autoguard BC Shielded IV Catheter with Blood Control Technology 20GA X….

Frequently asked questions

Is this FDA enforcement data for Becton Dickinson Infusion Therapy Systems, Inc. official?: Every record links directly to its primary FDA.gov source. Argus HQ aggregates and structures public FDA data; the verbatim FDA record is always the source of truth.
How many FDA actions has Becton Dickinson Infusion Therapy Systems, Inc. had?: Argus HQ has recorded 13 FDA events for Becton Dickinson Infusion Therapy Systems, Inc.: 0 warning letters, 13 recalls, 0 approvals, and 0 Form 483 inspection observations. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.
What is the most recent FDA action against Becton Dickinson Infusion Therapy Systems, Inc.?: The most recent FDA event Argus HQ has on file for Becton Dickinson Infusion Therapy Systems, Inc. is dated 2025-07-02, with a severity rating of "high" in Argus HQ's classification. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.
Does Argus HQ track new FDA actions for Becton Dickinson Infusion Therapy Systems, Inc. automatically?: Yes. Argus HQ ingests FDA sources daily, including FDA warning letters, recalls, drug and biologic approvals, and Form 483 inspection observations. When a new FDA action linked to Becton Dickinson Infusion Therapy Systems, Inc. is observed, this page's event count and history update automatically.

Every FDA action tied to this company, the week it happens.

Free weekly briefing. Real-time alerts on paid plans.

Compare with

Two different companies merged onto this page by mistake? Or a name variant missing? Tell us — corrections@argushq.ai

Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder

Verified from FDA.gov · Last updated: Jul 2, 2025

Cite this record

Reusing this data in reporting or research? Here’s a ready-made citation.

APA

Argus HQ Research (2025). Becton Dickinson Infusion Therapy Systems, Inc.'s Complete FDA Record. Digital Empire LLC. Retrieved from https://argushq.ai/company/becton-dickinson-infusion-therapy-systems-inc

MLA

"Becton Dickinson Infusion Therapy Systems, Inc.'s Complete FDA Record." Argus HQ Research, Digital Empire LLC, 2025, argushq.ai/company/becton-dickinson-infusion-therapy-systems-inc.

Chicago

Argus HQ Research. "Becton Dickinson Infusion Therapy Systems, Inc.'s Complete FDA Record." Digital Empire LLC. Accessed July 17, 2026. https://argushq.ai/company/becton-dickinson-infusion-therapy-systems-inc.

BibTeX

@misc{argushq_argushq_ai_company_becton_dickinson_infusion_therapy_systems_inc_2025,
  title = {Becton Dickinson Infusion Therapy Systems, Inc.'s Complete FDA Record},
  author = {{Argus HQ Research}},
  year = {2025},
  publisher = {Digital Empire LLC},
  url = {https://argushq.ai/company/becton-dickinson-infusion-therapy-systems-inc},
  note = {Accessed: July 17, 2026}
}

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗